The technological basis for adaptive ion beam therapy at MedAustron: Status and outlook

The ratio of patients who need a treatment adaptation due to anatomical variations at least once during the treatment course is significantly higher in light ion beam therapy (LIBT) than in photon therapy. The ballistic behaviour of ion beams makes them more sensitive to changes. Hence, the delivery...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Zeitschrift für medizinische Physik 2018-08, Vol.28 (3), p.196-210
Hauptverfasser: Stock, Markus, Georg, Dietmar, Ableitinger, Alexander, Zechner, Andrea, Utz, Alexander, Mumot, Marta, Kragl, Gabriele, Hopfgartner, Johannes, Gora, Joanna, Böhlen, Till, Grevillot, Loïc, Kuess, Peter, Steininger, Phil, Deutschmann, Heinz, Vatnitsky, Stanislav
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The ratio of patients who need a treatment adaptation due to anatomical variations at least once during the treatment course is significantly higher in light ion beam therapy (LIBT) than in photon therapy. The ballistic behaviour of ion beams makes them more sensitive to changes. Hence, the delivery of LIBT has always been supported by state of art image guidance. On the contrary CBCT technology was adapted for LIBT quite late. Adaptive concepts are being implemented more frequently in photon therapy and also efficient workflows are needed for LIBT. The MedAustron Ion Beam Therapy Centre was designed to allow the clinical implementation of adaptive image-guided concepts. The aim of this paper is to describe the current status and the potential future use of the technology installed at MedAustron. Specifically addressed is the beam delivery system, the patient alignment system, the treatment planning system as well as the Record & Verify system. Finally, an outlook is given on how high quality X-ray imaging, MR image guidance, fast and automated treatment planning as well as in vivo range verification methods could be integrated.
ISSN:0939-3889
1876-4436
DOI:10.1016/j.zemedi.2017.09.007